Tuberculosis presenting as immune thrombocytopenic purpura
<p>Abstract</p> <p>Background</p> <p>Although various hematologic abnormalities are seen in tuberculosis, immune thrombocytopenic purpura is a rare event.</p> <p>Case Presentation</p> <p>We report a case of a 29 year-old male who was presented wi...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Book |
| Published: |
BMC,
2004-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_11e2a0baf3374a4c9c3685eebc58bf7c | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Bahadir-Erdogan Beril |e author |
| 700 | 1 | 0 | |a Kunt-Uzaslan Esra |e author |
| 700 | 1 | 0 | |a Ozkocaman Vildan |e author |
| 700 | 1 | 0 | |a Ozcelik Tulay |e author |
| 700 | 1 | 0 | |a Ozkan Atilla |e author |
| 700 | 1 | 0 | |a Ali Ridvan |e author |
| 700 | 1 | 0 | |a Ozkalemkas Fahir |e author |
| 700 | 1 | 0 | |a Akalin Halis |e author |
| 245 | 0 | 0 | |a Tuberculosis presenting as immune thrombocytopenic purpura |
| 260 | |b BMC, |c 2004-09-01T00:00:00Z. | ||
| 500 | |a 10.1186/1476-0711-3-16 | ||
| 500 | |a 1476-0711 | ||
| 520 | |a <p>Abstract</p> <p>Background</p> <p>Although various hematologic abnormalities are seen in tuberculosis, immune thrombocytopenic purpura is a rare event.</p> <p>Case Presentation</p> <p>We report a case of a 29 year-old male who was presented with immune thrombocytopenia-induced hemoptysis, macroscopic hematuria and generalized petechiae. The patient was found to have clinical, microbiological and radiological evidence of active pulmonary tuberculosis. The immune thrombocytopenic purpura was successfully treated with anti-tuberculous drugs combined with corticosteroids and high dose immune globulin therapy.</p> <p>Conclusion</p> <p>Immune thrombocytopenic purpura can be one of the hematological manifestations of tuberculosis which has a global prevalence with increasing incidence secondary to HIV infection.</p> | ||
| 546 | |a EN | ||
| 690 | |a Tuberculosis | ||
| 690 | |a immune thrombocytopenic purpura | ||
| 690 | |a immune thrombocytopenia | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 690 | |a Infectious and parasitic diseases | ||
| 690 | |a RC109-216 | ||
| 690 | |a Microbiology | ||
| 690 | |a QR1-502 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Annals of Clinical Microbiology and Antimicrobials, Vol 3, Iss 1, p 16 (2004) | |
| 787 | 0 | |n http://www.ann-clinmicrob.com/content/3/1/16 | |
| 787 | 0 | |n https://doaj.org/toc/1476-0711 | |
| 856 | 4 | 1 | |u https://doaj.org/article/11e2a0baf3374a4c9c3685eebc58bf7c |z Connect to this object online. |